Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Supreme Court Seems To Disfavor Vermont's Prescriber Data Mining Law

This article was originally published in The Pink Sheet Daily

Executive Summary

Justices question the law's sole prohibition against use of the data for pharmaceutical marketing.

You may also be interested in...

Supreme Court To Address Prescriber Data, Free Speech And Pharma Marketing In Sorrell V. IMS

Does a Vermont law restricting the pharmaceutical industry's use of physician prescribing information violate the First Amendment? That's the question the Supreme Court will take up on April 26 when it hears oral arguments in Sorrell v. IMS Health Inc.

Data Mining Could End Up At Supreme Court After Second Circuit Ruling On Vermont Law

Appeals court says the state could pursue alternative measures to contain healthcare costs, such as academic detailing and mandating generic drugs for patients receiving Medicare Part D funds.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts